Handan He

An adenosine nucleoside inhibitor of dengue virus

Zheng Yin, Yen‐Liang Chen, Wouter Schul et al. · Proceedings of the National Academy of Sciences · 2009 · 389 citations · Full text

Dengue Virus, Molecular Virology, Medicine +9

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Barbara J. Ring, Jenny Y. Chien, Kimberly K. Adkison et al. · Journal of Pharmaceutical Sciences · 2011 · 198 citations

Pharmacokinetic Modeling, Medicine, Drug Discovery +8

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Patrick Poulin, Rhys D.O. Jones, Hannah M. Jones et al. · Journal of Pharmaceutical Sciences · 2011 · 170 citations

Precision Dosing, Physiologically Based Pharmacokinetics, Pharmacokinetic Modeling +9

Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans

Handan He, Phi Tran, Hequn Yin et al. · Drug Metabolism and Disposition · 2008 · 139 citations

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

Rhys D.O. Jones, Hannah M. Jones, Malcolm Rowland et al. · Journal of Pharmaceutical Sciences · 2011 · 133 citations

Translational Medicine, Pharmacokinetic Modeling, Part 2 +11